Wearable EEG Device Comprehensive Study by Type (Battery, Charge), Channel (32-channel Type, 14-channel Type, 5-channel Type, Others), Disease (TBI, Stroke, Dementia, Epilepsy, Headache,, Sleep), End Use (Medical, Neuromonitoring, Gaming, Others) Players and Region - Global Market Outlook to 2025

Wearable EEG Device Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Wearable EEG Device?
An electroencephalogram (EEG) is a test used to evaluate the electrical activity in the brain. Brain cells communicate with each other through electrical impulses. An EEG can be used to help detect potential problems associated with this activity. The factors contributing to the growth of the wearable EEG devices market are the rising development of wearable EEG devices and a growing number of players operating across the country conferring the highest manufacturing of the wearable EEG devices. Furthermore, the presence of supportive government initiatives and research in the field of neurology also boosts the market growth.

The market study is broken down by Type (Battery and Charge) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Wearable EEG Device market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Advanced Brain Monitoring, Inc. (United States), ANT Neuro (Netherlands), Natus Medical Incorporated (United States), Brain Products GmbH (Germany), Compumedics Neuroscan (Australia), Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands), EMOTIV (United States), g.tec medical engineering GmbH (Austria), Neuroelectrics (Spain) and Cadwell Industries, Inc. (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Wearable EEG Device market by Type, Application and Region.

On the basis of geography, the market of Wearable EEG Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Channel , the sub-segment i.e. 32-channel Type will boost the Wearable EEG Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disease, the sub-segment i.e. TBI will boost the Wearable EEG Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Medical will boost the Wearable EEG Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Increasing demand for non-invasive and minimally invasive devices

Market Drivers
  • Increasing incidence and prevalence of neurological disorders
  • Growing incidence of traumatic brain injuries

Opportunities
  • Growing healthcare market in emerging economies

Restraints
  • Unfavorable reimbursement policies

Challenges
  • Issues related to product approval and commercialization


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Hospitals, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Battery
  • Charge
By Channel
  • 32-channel Type
  • 14-channel Type
  • 5-channel Type
  • Others

By Disease
  • TBI
  • Stroke
  • Dementia
  • Epilepsy
  • Headache,
  • Sleep

By End Use
  • Medical
  • Neuromonitoring
  • Gaming
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing incidence and prevalence of neurological disorders
      • 3.2.2. Growing incidence of traumatic brain injuries
    • 3.3. Market Challenges
      • 3.3.1. Issues related to product approval and commercialization
    • 3.4. Market Trends
      • 3.4.1. Increasing demand for non-invasive and minimally invasive devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Wearable EEG Device, by Type, Channel , Disease, End Use and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Wearable EEG Device (Value)
      • 5.2.1. Global Wearable EEG Device by: Type (Value)
        • 5.2.1.1. Battery
        • 5.2.1.2. Charge
      • 5.2.2. Global Wearable EEG Device by: Disease (Value)
        • 5.2.2.1. TBI
        • 5.2.2.2. Stroke
        • 5.2.2.3. Dementia
        • 5.2.2.4. Epilepsy
        • 5.2.2.5. Headache,
        • 5.2.2.6. Sleep
      • 5.2.3. Global Wearable EEG Device by: End Use (Value)
        • 5.2.3.1. Medical
        • 5.2.3.2. Neuromonitoring
        • 5.2.3.3. Gaming
        • 5.2.3.4. Others
      • 5.2.4. Global Wearable EEG Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Wearable EEG Device (Volume)
      • 5.3.1. Global Wearable EEG Device by: Type (Volume)
        • 5.3.1.1. Battery
        • 5.3.1.2. Charge
      • 5.3.2. Global Wearable EEG Device by: Disease (Volume)
        • 5.3.2.1. TBI
        • 5.3.2.2. Stroke
        • 5.3.2.3. Dementia
        • 5.3.2.4. Epilepsy
        • 5.3.2.5. Headache,
        • 5.3.2.6. Sleep
      • 5.3.3. Global Wearable EEG Device by: End Use (Volume)
        • 5.3.3.1. Medical
        • 5.3.3.2. Neuromonitoring
        • 5.3.3.3. Gaming
        • 5.3.3.4. Others
      • 5.3.4. Global Wearable EEG Device Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Wearable EEG Device (Price)
      • 5.4.1. Global Wearable EEG Device by: Type (Price)
  • 6. Wearable EEG Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced Brain Monitoring, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ANT Neuro (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Natus Medical Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Brain Products GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Compumedics Neuroscan (Australia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. EMOTIV (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. G.tec medical engineering GmbH (Austria)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Neuroelectrics (Spain)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cadwell Industries, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Wearable EEG Device Sale, by Type, Channel , Disease, End Use and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Wearable EEG Device (Value)
      • 7.2.1. Global Wearable EEG Device by: Type (Value)
        • 7.2.1.1. Battery
        • 7.2.1.2. Charge
      • 7.2.2. Global Wearable EEG Device by: Disease (Value)
        • 7.2.2.1. TBI
        • 7.2.2.2. Stroke
        • 7.2.2.3. Dementia
        • 7.2.2.4. Epilepsy
        • 7.2.2.5. Headache,
        • 7.2.2.6. Sleep
      • 7.2.3. Global Wearable EEG Device by: End Use (Value)
        • 7.2.3.1. Medical
        • 7.2.3.2. Neuromonitoring
        • 7.2.3.3. Gaming
        • 7.2.3.4. Others
      • 7.2.4. Global Wearable EEG Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Wearable EEG Device (Volume)
      • 7.3.1. Global Wearable EEG Device by: Type (Volume)
        • 7.3.1.1. Battery
        • 7.3.1.2. Charge
      • 7.3.2. Global Wearable EEG Device by: Disease (Volume)
        • 7.3.2.1. TBI
        • 7.3.2.2. Stroke
        • 7.3.2.3. Dementia
        • 7.3.2.4. Epilepsy
        • 7.3.2.5. Headache,
        • 7.3.2.6. Sleep
      • 7.3.3. Global Wearable EEG Device by: End Use (Volume)
        • 7.3.3.1. Medical
        • 7.3.3.2. Neuromonitoring
        • 7.3.3.3. Gaming
        • 7.3.3.4. Others
      • 7.3.4. Global Wearable EEG Device Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Wearable EEG Device (Price)
      • 7.4.1. Global Wearable EEG Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Wearable EEG Device: by Type(USD Million)
  • Table 2. Wearable EEG Device Battery , by Region USD Million (2015-2020)
  • Table 3. Wearable EEG Device Charge , by Region USD Million (2015-2020)
  • Table 4. Wearable EEG Device: by Disease(USD Million)
  • Table 5. Wearable EEG Device TBI , by Region USD Million (2015-2020)
  • Table 6. Wearable EEG Device Stroke , by Region USD Million (2015-2020)
  • Table 7. Wearable EEG Device Dementia , by Region USD Million (2015-2020)
  • Table 8. Wearable EEG Device Epilepsy , by Region USD Million (2015-2020)
  • Table 9. Wearable EEG Device Headache, , by Region USD Million (2015-2020)
  • Table 10. Wearable EEG Device Sleep , by Region USD Million (2015-2020)
  • Table 11. Wearable EEG Device: by End Use(USD Million)
  • Table 12. Wearable EEG Device Medical , by Region USD Million (2015-2020)
  • Table 13. Wearable EEG Device Neuromonitoring , by Region USD Million (2015-2020)
  • Table 14. Wearable EEG Device Gaming , by Region USD Million (2015-2020)
  • Table 15. Wearable EEG Device Others , by Region USD Million (2015-2020)
  • Table 16. South America Wearable EEG Device, by Country USD Million (2015-2020)
  • Table 17. South America Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 18. South America Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 19. South America Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 20. South America Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 21. Brazil Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 22. Brazil Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 23. Brazil Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 24. Brazil Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 25. Argentina Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 26. Argentina Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 27. Argentina Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 28. Argentina Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 29. Rest of South America Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 31. Rest of South America Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 32. Rest of South America Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 33. Asia Pacific Wearable EEG Device, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 36. Asia Pacific Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 37. Asia Pacific Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 38. China Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 39. China Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 40. China Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 41. China Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 42. Japan Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 43. Japan Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 44. Japan Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 45. Japan Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 46. India Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 47. India Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 48. India Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 49. India Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 50. South Korea Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 51. South Korea Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 52. South Korea Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 53. South Korea Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 54. Taiwan Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 55. Taiwan Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 56. Taiwan Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 57. Taiwan Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 58. Australia Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 59. Australia Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 60. Australia Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 61. Australia Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 66. Europe Wearable EEG Device, by Country USD Million (2015-2020)
  • Table 67. Europe Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 68. Europe Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 69. Europe Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 70. Europe Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 71. Germany Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 72. Germany Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 73. Germany Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 74. Germany Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 75. France Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 76. France Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 77. France Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 78. France Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 79. Italy Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 80. Italy Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 81. Italy Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 82. Italy Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 83. United Kingdom Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 85. United Kingdom Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 86. United Kingdom Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 87. Netherlands Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 88. Netherlands Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 89. Netherlands Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 90. Netherlands Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 91. Rest of Europe Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 93. Rest of Europe Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 94. Rest of Europe Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 95. MEA Wearable EEG Device, by Country USD Million (2015-2020)
  • Table 96. MEA Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 97. MEA Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 98. MEA Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 99. MEA Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 100. Middle East Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 101. Middle East Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 102. Middle East Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 103. Middle East Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 104. Africa Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 105. Africa Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 106. Africa Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 107. Africa Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 108. North America Wearable EEG Device, by Country USD Million (2015-2020)
  • Table 109. North America Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 110. North America Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 111. North America Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 112. North America Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 113. United States Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 114. United States Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 115. United States Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 116. United States Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 117. Canada Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 118. Canada Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 119. Canada Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 120. Canada Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 121. Mexico Wearable EEG Device, by Type USD Million (2015-2020)
  • Table 122. Mexico Wearable EEG Device, by Channel USD Million (2015-2020)
  • Table 123. Mexico Wearable EEG Device, by Disease USD Million (2015-2020)
  • Table 124. Mexico Wearable EEG Device, by End Use USD Million (2015-2020)
  • Table 125. Wearable EEG Device Sales: by Type(K Unit)
  • Table 126. Wearable EEG Device Sales Battery , by Region K Unit (2015-2020)
  • Table 127. Wearable EEG Device Sales Charge , by Region K Unit (2015-2020)
  • Table 128. Wearable EEG Device Sales: by Disease(K Unit)
  • Table 129. Wearable EEG Device Sales TBI , by Region K Unit (2015-2020)
  • Table 130. Wearable EEG Device Sales Stroke , by Region K Unit (2015-2020)
  • Table 131. Wearable EEG Device Sales Dementia , by Region K Unit (2015-2020)
  • Table 132. Wearable EEG Device Sales Epilepsy , by Region K Unit (2015-2020)
  • Table 133. Wearable EEG Device Sales Headache, , by Region K Unit (2015-2020)
  • Table 134. Wearable EEG Device Sales Sleep , by Region K Unit (2015-2020)
  • Table 135. Wearable EEG Device Sales: by End Use(K Unit)
  • Table 136. Wearable EEG Device Sales Medical , by Region K Unit (2015-2020)
  • Table 137. Wearable EEG Device Sales Neuromonitoring , by Region K Unit (2015-2020)
  • Table 138. Wearable EEG Device Sales Gaming , by Region K Unit (2015-2020)
  • Table 139. Wearable EEG Device Sales Others , by Region K Unit (2015-2020)
  • Table 140. South America Wearable EEG Device Sales, by Country K Unit (2015-2020)
  • Table 141. South America Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 142. South America Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 143. South America Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 144. South America Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 145. Brazil Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 146. Brazil Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 147. Brazil Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 148. Brazil Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 149. Argentina Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 150. Argentina Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 151. Argentina Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 152. Argentina Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 153. Rest of South America Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 154. Rest of South America Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 155. Rest of South America Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 156. Rest of South America Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 157. Asia Pacific Wearable EEG Device Sales, by Country K Unit (2015-2020)
  • Table 158. Asia Pacific Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 159. Asia Pacific Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 160. Asia Pacific Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 161. Asia Pacific Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 162. China Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 163. China Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 164. China Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 165. China Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 166. Japan Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 167. Japan Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 168. Japan Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 169. Japan Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 170. India Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 171. India Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 172. India Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 173. India Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 174. South Korea Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 175. South Korea Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 176. South Korea Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 177. South Korea Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 178. Taiwan Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 179. Taiwan Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 180. Taiwan Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 181. Taiwan Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 182. Australia Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 183. Australia Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 184. Australia Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 185. Australia Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 186. Rest of Asia-Pacific Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 187. Rest of Asia-Pacific Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 188. Rest of Asia-Pacific Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 189. Rest of Asia-Pacific Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 190. Europe Wearable EEG Device Sales, by Country K Unit (2015-2020)
  • Table 191. Europe Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 192. Europe Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 193. Europe Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 194. Europe Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 195. Germany Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 196. Germany Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 197. Germany Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 198. Germany Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 199. France Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 200. France Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 201. France Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 202. France Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 203. Italy Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 204. Italy Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 205. Italy Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 206. Italy Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 207. United Kingdom Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 208. United Kingdom Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 209. United Kingdom Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 210. United Kingdom Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 211. Netherlands Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 212. Netherlands Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 213. Netherlands Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 214. Netherlands Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 215. Rest of Europe Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 216. Rest of Europe Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 217. Rest of Europe Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 218. Rest of Europe Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 219. MEA Wearable EEG Device Sales, by Country K Unit (2015-2020)
  • Table 220. MEA Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 221. MEA Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 222. MEA Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 223. MEA Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 224. Middle East Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 225. Middle East Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 226. Middle East Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 227. Middle East Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 228. Africa Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 229. Africa Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 230. Africa Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 231. Africa Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 232. North America Wearable EEG Device Sales, by Country K Unit (2015-2020)
  • Table 233. North America Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 234. North America Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 235. North America Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 236. North America Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 237. United States Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 238. United States Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 239. United States Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 240. United States Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 241. Canada Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 242. Canada Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 243. Canada Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 244. Canada Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 245. Mexico Wearable EEG Device Sales, by Type K Unit (2015-2020)
  • Table 246. Mexico Wearable EEG Device Sales, by Channel K Unit (2015-2020)
  • Table 247. Mexico Wearable EEG Device Sales, by Disease K Unit (2015-2020)
  • Table 248. Mexico Wearable EEG Device Sales, by End Use K Unit (2015-2020)
  • Table 249. Wearable EEG Device: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Wearable EEG Device: by Type(USD Million)
  • Table 261. Wearable EEG Device Battery , by Region USD Million (2021-2026)
  • Table 262. Wearable EEG Device Charge , by Region USD Million (2021-2026)
  • Table 263. Wearable EEG Device: by Disease(USD Million)
  • Table 264. Wearable EEG Device TBI , by Region USD Million (2021-2026)
  • Table 265. Wearable EEG Device Stroke , by Region USD Million (2021-2026)
  • Table 266. Wearable EEG Device Dementia , by Region USD Million (2021-2026)
  • Table 267. Wearable EEG Device Epilepsy , by Region USD Million (2021-2026)
  • Table 268. Wearable EEG Device Headache, , by Region USD Million (2021-2026)
  • Table 269. Wearable EEG Device Sleep , by Region USD Million (2021-2026)
  • Table 270. Wearable EEG Device: by End Use(USD Million)
  • Table 271. Wearable EEG Device Medical , by Region USD Million (2021-2026)
  • Table 272. Wearable EEG Device Neuromonitoring , by Region USD Million (2021-2026)
  • Table 273. Wearable EEG Device Gaming , by Region USD Million (2021-2026)
  • Table 274. Wearable EEG Device Others , by Region USD Million (2021-2026)
  • Table 275. South America Wearable EEG Device, by Country USD Million (2021-2026)
  • Table 276. South America Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 277. South America Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 278. South America Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 279. South America Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 280. Brazil Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 281. Brazil Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 282. Brazil Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 283. Brazil Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 284. Argentina Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 285. Argentina Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 286. Argentina Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 287. Argentina Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 288. Rest of South America Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 289. Rest of South America Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 290. Rest of South America Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 291. Rest of South America Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 292. Asia Pacific Wearable EEG Device, by Country USD Million (2021-2026)
  • Table 293. Asia Pacific Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 294. Asia Pacific Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 295. Asia Pacific Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 296. Asia Pacific Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 297. China Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 298. China Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 299. China Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 300. China Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 301. Japan Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 302. Japan Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 303. Japan Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 304. Japan Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 305. India Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 306. India Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 307. India Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 308. India Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 309. South Korea Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 310. South Korea Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 311. South Korea Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 312. South Korea Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 313. Taiwan Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 314. Taiwan Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 315. Taiwan Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 316. Taiwan Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 317. Australia Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 318. Australia Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 319. Australia Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 320. Australia Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 321. Rest of Asia-Pacific Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 322. Rest of Asia-Pacific Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 323. Rest of Asia-Pacific Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 324. Rest of Asia-Pacific Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 325. Europe Wearable EEG Device, by Country USD Million (2021-2026)
  • Table 326. Europe Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 327. Europe Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 328. Europe Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 329. Europe Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 330. Germany Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 331. Germany Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 332. Germany Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 333. Germany Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 334. France Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 335. France Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 336. France Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 337. France Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 338. Italy Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 339. Italy Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 340. Italy Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 341. Italy Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 342. United Kingdom Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 343. United Kingdom Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 344. United Kingdom Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 345. United Kingdom Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 346. Netherlands Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 347. Netherlands Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 348. Netherlands Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 349. Netherlands Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 350. Rest of Europe Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 351. Rest of Europe Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 352. Rest of Europe Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 353. Rest of Europe Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 354. MEA Wearable EEG Device, by Country USD Million (2021-2026)
  • Table 355. MEA Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 356. MEA Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 357. MEA Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 358. MEA Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 359. Middle East Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 360. Middle East Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 361. Middle East Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 362. Middle East Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 363. Africa Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 364. Africa Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 365. Africa Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 366. Africa Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 367. North America Wearable EEG Device, by Country USD Million (2021-2026)
  • Table 368. North America Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 369. North America Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 370. North America Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 371. North America Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 372. United States Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 373. United States Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 374. United States Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 375. United States Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 376. Canada Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 377. Canada Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 378. Canada Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 379. Canada Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 380. Mexico Wearable EEG Device, by Type USD Million (2021-2026)
  • Table 381. Mexico Wearable EEG Device, by Channel USD Million (2021-2026)
  • Table 382. Mexico Wearable EEG Device, by Disease USD Million (2021-2026)
  • Table 383. Mexico Wearable EEG Device, by End Use USD Million (2021-2026)
  • Table 384. Wearable EEG Device Sales: by Type(K Unit)
  • Table 385. Wearable EEG Device Sales Battery , by Region K Unit (2021-2026)
  • Table 386. Wearable EEG Device Sales Charge , by Region K Unit (2021-2026)
  • Table 387. Wearable EEG Device Sales: by Disease(K Unit)
  • Table 388. Wearable EEG Device Sales TBI , by Region K Unit (2021-2026)
  • Table 389. Wearable EEG Device Sales Stroke , by Region K Unit (2021-2026)
  • Table 390. Wearable EEG Device Sales Dementia , by Region K Unit (2021-2026)
  • Table 391. Wearable EEG Device Sales Epilepsy , by Region K Unit (2021-2026)
  • Table 392. Wearable EEG Device Sales Headache, , by Region K Unit (2021-2026)
  • Table 393. Wearable EEG Device Sales Sleep , by Region K Unit (2021-2026)
  • Table 394. Wearable EEG Device Sales: by End Use(K Unit)
  • Table 395. Wearable EEG Device Sales Medical , by Region K Unit (2021-2026)
  • Table 396. Wearable EEG Device Sales Neuromonitoring , by Region K Unit (2021-2026)
  • Table 397. Wearable EEG Device Sales Gaming , by Region K Unit (2021-2026)
  • Table 398. Wearable EEG Device Sales Others , by Region K Unit (2021-2026)
  • Table 399. South America Wearable EEG Device Sales, by Country K Unit (2021-2026)
  • Table 400. South America Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 401. South America Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 402. South America Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 403. South America Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 404. Brazil Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 405. Brazil Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 406. Brazil Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 407. Brazil Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 408. Argentina Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 409. Argentina Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 410. Argentina Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 411. Argentina Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 412. Rest of South America Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 413. Rest of South America Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 414. Rest of South America Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 415. Rest of South America Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 416. Asia Pacific Wearable EEG Device Sales, by Country K Unit (2021-2026)
  • Table 417. Asia Pacific Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 418. Asia Pacific Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 419. Asia Pacific Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 420. Asia Pacific Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 421. China Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 422. China Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 423. China Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 424. China Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 425. Japan Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 426. Japan Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 427. Japan Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 428. Japan Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 429. India Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 430. India Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 431. India Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 432. India Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 433. South Korea Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 434. South Korea Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 435. South Korea Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 436. South Korea Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 437. Taiwan Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 438. Taiwan Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 439. Taiwan Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 440. Taiwan Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 441. Australia Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 442. Australia Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 443. Australia Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 444. Australia Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 445. Rest of Asia-Pacific Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 446. Rest of Asia-Pacific Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 447. Rest of Asia-Pacific Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 448. Rest of Asia-Pacific Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 449. Europe Wearable EEG Device Sales, by Country K Unit (2021-2026)
  • Table 450. Europe Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 451. Europe Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 452. Europe Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 453. Europe Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 454. Germany Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 455. Germany Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 456. Germany Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 457. Germany Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 458. France Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 459. France Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 460. France Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 461. France Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 462. Italy Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 463. Italy Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 464. Italy Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 465. Italy Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 466. United Kingdom Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 467. United Kingdom Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 468. United Kingdom Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 469. United Kingdom Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 470. Netherlands Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 471. Netherlands Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 472. Netherlands Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 473. Netherlands Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 474. Rest of Europe Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 475. Rest of Europe Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 476. Rest of Europe Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 477. Rest of Europe Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 478. MEA Wearable EEG Device Sales, by Country K Unit (2021-2026)
  • Table 479. MEA Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 480. MEA Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 481. MEA Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 482. MEA Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 483. Middle East Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 484. Middle East Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 485. Middle East Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 486. Middle East Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 487. Africa Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 488. Africa Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 489. Africa Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 490. Africa Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 491. North America Wearable EEG Device Sales, by Country K Unit (2021-2026)
  • Table 492. North America Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 493. North America Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 494. North America Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 495. North America Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 496. United States Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 497. United States Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 498. United States Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 499. United States Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 500. Canada Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 501. Canada Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 502. Canada Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 503. Canada Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 504. Mexico Wearable EEG Device Sales, by Type K Unit (2021-2026)
  • Table 505. Mexico Wearable EEG Device Sales, by Channel K Unit (2021-2026)
  • Table 506. Mexico Wearable EEG Device Sales, by Disease K Unit (2021-2026)
  • Table 507. Mexico Wearable EEG Device Sales, by End Use K Unit (2021-2026)
  • Table 508. Wearable EEG Device: by Type(USD/Units)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Wearable EEG Device: by Type USD Million (2015-2020)
  • Figure 5. Global Wearable EEG Device: by Disease USD Million (2015-2020)
  • Figure 6. Global Wearable EEG Device: by End Use USD Million (2015-2020)
  • Figure 7. South America Wearable EEG Device Share (%), by Country
  • Figure 8. Asia Pacific Wearable EEG Device Share (%), by Country
  • Figure 9. Europe Wearable EEG Device Share (%), by Country
  • Figure 10. MEA Wearable EEG Device Share (%), by Country
  • Figure 11. North America Wearable EEG Device Share (%), by Country
  • Figure 12. Global Wearable EEG Device: by Type K Unit (2015-2020)
  • Figure 13. Global Wearable EEG Device: by Disease K Unit (2015-2020)
  • Figure 14. Global Wearable EEG Device: by End Use K Unit (2015-2020)
  • Figure 15. South America Wearable EEG Device Share (%), by Country
  • Figure 16. Asia Pacific Wearable EEG Device Share (%), by Country
  • Figure 17. Europe Wearable EEG Device Share (%), by Country
  • Figure 18. MEA Wearable EEG Device Share (%), by Country
  • Figure 19. North America Wearable EEG Device Share (%), by Country
  • Figure 20. Global Wearable EEG Device: by Type USD/Units (2015-2020)
  • Figure 21. Global Wearable EEG Device share by Players 2020 (%)
  • Figure 22. Global Wearable EEG Device share by Players (Top 3) 2020(%)
  • Figure 23. Global Wearable EEG Device share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Advanced Brain Monitoring, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Advanced Brain Monitoring, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. ANT Neuro (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. ANT Neuro (Netherlands) Revenue: by Geography 2020
  • Figure 29. Natus Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 30. Natus Medical Incorporated (United States) Revenue: by Geography 2020
  • Figure 31. Brain Products GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Brain Products GmbH (Germany) Revenue: by Geography 2020
  • Figure 33. Compumedics Neuroscan (Australia) Revenue, Net Income and Gross profit
  • Figure 34. Compumedics Neuroscan (Australia) Revenue: by Geography 2020
  • Figure 35. Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 36. Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands) Revenue: by Geography 2020
  • Figure 37. EMOTIV (United States) Revenue, Net Income and Gross profit
  • Figure 38. EMOTIV (United States) Revenue: by Geography 2020
  • Figure 39. G.tec medical engineering GmbH (Austria) Revenue, Net Income and Gross profit
  • Figure 40. G.tec medical engineering GmbH (Austria) Revenue: by Geography 2020
  • Figure 41. Neuroelectrics (Spain) Revenue, Net Income and Gross profit
  • Figure 42. Neuroelectrics (Spain) Revenue: by Geography 2020
  • Figure 43. Cadwell Industries, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Cadwell Industries, Inc. (United States) Revenue: by Geography 2020
  • Figure 45. Global Wearable EEG Device: by Type USD Million (2021-2026)
  • Figure 46. Global Wearable EEG Device: by Disease USD Million (2021-2026)
  • Figure 47. Global Wearable EEG Device: by End Use USD Million (2021-2026)
  • Figure 48. South America Wearable EEG Device Share (%), by Country
  • Figure 49. Asia Pacific Wearable EEG Device Share (%), by Country
  • Figure 50. Europe Wearable EEG Device Share (%), by Country
  • Figure 51. MEA Wearable EEG Device Share (%), by Country
  • Figure 52. North America Wearable EEG Device Share (%), by Country
  • Figure 53. Global Wearable EEG Device: by Type K Unit (2021-2026)
  • Figure 54. Global Wearable EEG Device: by Disease K Unit (2021-2026)
  • Figure 55. Global Wearable EEG Device: by End Use K Unit (2021-2026)
  • Figure 56. South America Wearable EEG Device Share (%), by Country
  • Figure 57. Asia Pacific Wearable EEG Device Share (%), by Country
  • Figure 58. Europe Wearable EEG Device Share (%), by Country
  • Figure 59. MEA Wearable EEG Device Share (%), by Country
  • Figure 60. North America Wearable EEG Device Share (%), by Country
  • Figure 61. Global Wearable EEG Device: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Advanced Brain Monitoring, Inc. (United States)
  • ANT Neuro (Netherlands)
  • Natus Medical Incorporated (United States)
  • Brain Products GmbH (Germany)
  • Compumedics Neuroscan (Australia)
  • Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands)
  • EMOTIV (United States)
  • g.tec medical engineering GmbH (Austria)
  • Neuroelectrics (Spain)
  • Cadwell Industries, Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2020 206 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Advanced Brain Monitoring, Inc. (United States), ANT Neuro (Netherlands), Natus Medical Incorporated (United States), Brain Products GmbH (Germany), Compumedics Neuroscan (Australia), Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands), EMOTIV (United States), g.tec medical engineering GmbH (Austria), Neuroelectrics (Spain) and Cadwell Industries, Inc. (United States) etc.
Analysts at AMA estimates Wearable EEG Device Market to reach USDXXX by 2026.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Wearable EEG Device Report?